Teladoc Health, Inc. (TDOC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 631,900 | 629,369 | 640,508 | 642,444 |
| Sales | 49,951 | 48,693 | 47,465 | 50,438 |
| Restructuring costs | 5,692 | 4,347 | 3,580 | 1,500 |
| Technology and development | 68,784 | 69,958 | 72,383 | 76,751 |
| Advertising and marketing | 167,547 | 168,185 | 177,462 | 170,270 |
| Goodwill impairment | - | 59,138 | - | 790,000 |
| General and administrative | 108,114 | 112,774 | 114,245 | 109,552 |
| Depreciation of property and equipment | 4,338 | 3,564 | 2,666 | 1,703 |
| Cost of revenue (exclusive of depreciation and amortization, which are shown separately below) | 190,537 | 196,829 | 179,745 | 188,059 |
| Acquisition, integration, and transformation costs | 2,658 | 2,188 | 457 | 457 |
| Amortization of intangible assets | 88,664 | 84,304 | 86,906 | 94,862 |
| Total costs and expenses | 686,285 | 749,980 | 684,909 | 1,483,592 |
| Loss from operations | -54,385 | -120,611 | -44,401 | -841,148 |
| Interest income | 10,064 | 12,674 | 15,326 | 13,572 |
| Interest expense | 4,473 | 5,765 | 5,660 | 5,648 |
| Other expense (income), net | 8,371 | 2,435 | 2,239 | -563 |
| Loss before provision for income taxes | -40,423 | -111,267 | -32,496 | -833,787 |
| Provision for income taxes | -7,763 | -18,255 | 780 | 3,884 |
| Net loss | -32,660 | -93,012 | -33,276 | -837,671 |
| Currency translation adjustment | 1,847 | 1,143 | 1,860 | -337 |
| Comprehensive loss | -30,813 | -91,869 | -31,416 | -838,008 |
| Net loss per share, basic (in dollars per share) | -0.19 | -0.53 | -0.19 | -4.92 |
| Net loss per share, diluted (in dollars per share) | -0.19 | -0.53 | -0.19 | -4.92 |
| Weighted-average shares used to compute basic net loss per share (in shares) | 175,917,380 | 174,154,128 | 171,496,282 | 170,229,583 |
| Weighted-average shares used to compute diluted net loss per share (in shares) | 175,917,380 | 174,154,128 | 171,496,282 | 170,229,583 |